| 摘要 |
<p>Peptides are disclosed which have the general formula (I) <IMAGE> wherein R1 is H-, H-Pro-, H-Gly-Pro, H-Lys-Gly-Pro-, H-Thr-Lys-Gly-Pro-, H-Leu-Thr-Lys-Gly-Pro-, H-Phe-Leu-Thr-Lys-Gly-Pro-, H-Ser-Phe-Leu-Thr-Lys-Gly-Pro-, H-Gly-Ser-Phe-Leu-Thr-Lys-Gly-Pro-, H-Gln-Gly-Ser-Phe-Leu-Thr-Lys-Gly-Pro-, H-Asn-Gln-Gly-Ser-Phe-Leu-Thr-Lys-Gly-Pro-, or H-Gly-Asn-Gln-Gly-Ser-Phe-Leu-Thr-Lys-Gly-Pro-, and R2 is -OH, -Gln-OH, -Gln-Gly-OH, -Gln-Gly-Asn-OH, or -Gln-Gly-Asn-Phe-OH, with the proviso that R1 is not H-Thr-Lys-Gly-Pro- when R2 is -Gln-Gly-Asn-Phe-OH, or a pharmaceutically acceptable salt thereof. Furthermore, pharmaceutical compositions are disclosed which contain said peptides.</p> |
